NWAM LLC’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $520K | Buy |
13,340
+921
| +7% | +$35.9K | 0.04% | 324 |
|
|
2025
Q1 | $481K | Buy |
12,419
+3,499
| +39% | +$136K | 0.04% | 320 |
|
|
2024
Q4 | $302K | Sell |
8,920
-6,365
| -42% | -$215K | 0.02% | 481 |
|
|
2024
Q3 | $625K | Buy |
+15,285
| New | +$625K | 0.04% | 340 |
|
|
2024
Q2 | – | Sell |
-16,080
| Closed | -$710K | – | 304 |
|
|
2024
Q1 | $710K | Buy |
16,080
+8,976
| +126% | +$396K | 0.06% | 272 |
|
|
2023
Q4 | $263K | Sell |
7,104
-1,719
| -19% | -$63.7K | 0.02% | 467 |
|
|
2023
Q3 | $320K | Buy |
8,823
+1,246
| +16% | +$45.2K | 0.03% | 368 |
|
|
2023
Q2 | $270K | Buy |
7,577
+1,345
| +22% | +$47.9K | 0.02% | 440 |
|
|
2023
Q1 | $222K | Buy |
+6,232
| New | +$222K | 0.02% | 434 |
|
|
2017
Q4 | – | Sell |
-4,558
| Closed | -$231K | – | 332 |
|
|
2017
Q3 | $231K | Buy |
+4,558
| New | +$231K | 0.06% | 273 |
|
|
2017
Q2 | – | Sell |
-5,561
| Closed | -$293K | – | 329 |
|
|
2017
Q1 | $293K | Buy |
+5,561
| New | +$293K | 0.09% | 221 |
|
|
2016
Q4 | – | Sell |
-5,832
| Closed | -$314K | – | 293 |
|
|
2016
Q3 | $314K | Buy |
+5,832
| New | +$314K | 0.02% | 186 |
|
|
2015
Q2 | – | Sell |
-5,146
| Closed | -$297K | – | 256 |
|
|
2015
Q1 | $297K | Sell |
5,146
-7
| -0.1% | -$404 | 0.13% | 166 |
|
|
2014
Q4 | $275K | Sell |
5,153
-498
| -9% | -$26.6K | 0.12% | 166 |
|
|
2014
Q3 | $325K | Buy |
5,651
+621
| +12% | +$35.7K | 0.12% | 183 |
|
|
2014
Q2 | $336K | Buy |
5,030
+186
| +4% | +$12.4K | 0.1% | 192 |
|
|
2014
Q1 | $324K | Buy |
4,844
+1,719
| +55% | +$115K | 0.11% | 168 |
|
|
2013
Q4 | $209K | Sell |
3,125
-201
| -6% | -$13.4K | 0.11% | 150 |
|
|
2013
Q3 | $209K | Sell |
3,326
-12
| -0.4% | -$754 | 0.1% | 170 |
|
|
2013
Q2 | $209K | Buy |
+3,338
| New | +$209K | 0.11% | 170 |
|